GRÜNENTHAL GMBH
🏢 View company profile →74Patents
74Active
74Granted
55Portfolio score
Filing activity: Jul 23, 2007 → Jun 15, 2022 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9629807B2 | Abuse-proofed dosage form | Human Necessities | 20 | Active |
| US9737490B2 | Tamper resistant dosage form with bimodal release profile | Human Necessities | 18 | Active |
| US9675610B2 | Abuse-proofed dosage form | Human Necessities | 17 | Active |
| US9925146B2 | Oxidation-stabilized tamper-resistant dosage form | Human Necessities | 14 | Active |
| US9855263B2 | Tamper-resistant dosage form with immediate release and resistance against solvent extraction | Human Necessities | 13 | Active |
| US9750701B2 | Pharmaceutical dosage form | Emerging Cross-Sectional Technologies | 12 | Active |
| US10130591B2 | Abuse-proofed dosage form | Human Necessities | 7 | Active |
| US10154966B2 | Tamper-resistant dosage form containing one or more particles | Human Necessities | 6 | Active |
| US10369109B2 | Abuse-proofed dosage form | Human Necessities | 4 | Active |
| US9302988B2 | Fluoromethyl-substituted pyrrole carboxamides | Chemistry; Metallurgy | 4 | Active |
| US10624862B2 | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer | Performing Operations; Transporting | 4 | Active |
| US10058548B2 | Abuse-proofed dosage form | Performing Operations; Transporting | 3 | Active |
| US8969368B2 | Crystalline, anhydrous forms of oxymorphone hydrochloride | Chemistry; Metallurgy | 2 | Active |
| US8586755B2 | Substituted nicotinamides as KCNQ2/3 modulators | Chemistry; Metallurgy | 2 | Active |
| US10981918B2 | Further substituted triazolo quinoxaline derivatives | Human Necessities | 2 | Active |
| US10576047B2 | Formulations for the treatment of pain | Human Necessities | 2 | Active |
| US10022353B2 | Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function | Human Necessities | 1 | Active |
| US9234630B2 | Method and device for supplying liquids to analysis units and liquid handling systems | Emerging Cross-Sectional Technologies | 1 | Active |
| US9913814B2 | Tamper resistant immediate release capsule formulation comprising tapentadol | Human Necessities | 1 | Active |
| US11344512B2 | Titration of tapentadol | Human Necessities | 1 | Active |
| US9168259B2 | Substituted 6-amino-nicotinamides as KCNQ2/3 modulators | Chemistry; Metallurgy | 1 | Active |
| US8877974B2 | Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropy1)-phenol | Chemistry; Metallurgy | 1 | Active |
| US10449547B2 | Preparation of a powdery pharmaceutical composition by means of cryo-milling | Performing Operations; Transporting | 1 | Active |
| US8669399B2 | Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds | Chemistry; Metallurgy | 1 | Active |
| US8835689B2 | Substituted 4-aminocyclohexane derivatives | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.